Literature DB >> 6501806

Circadian variation in plasma dopamine levels in man.

J R Sowers, N Vlachakis.   

Abstract

Nocturnal and daytime recumbent secretory patterns of norepinephrine, epinephrine and dopamine were determined at 30 min intervals in 9 normotensive males. Plasma levels of dopamine as well as those of norepinephrine and epinephrine followed a circadian pattern in these recumbent males. Plasma levels of dopamine were more closely related to clock time (r = -0.54, p less than 0.001) than either norepinephrine or epinephrine levels. As for norepinephrine and epinephrine, the sleep period in all 9 males was characterized by a paucity of dopamine secretory peaks as well as lower mean dopamine levels than during the awake state. There was a strong relationship between the circadian changes in plasma dopamine levels and those of norepinephrine (r = 0.92) and epinephrine (r = 0.78) throughout the 24-h period of recumbency. These interrelationships are consistent with a common regulatory mechanism governing the sleep/wake and/or rest/activity in plasma catecholamine levels.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6501806     DOI: 10.1007/BF03351014

Source DB:  PubMed          Journal:  J Endocrinol Invest        ISSN: 0391-4097            Impact factor:   4.256


  23 in total

1.  Dopaminergic inhibition of adrenergic neurotransmission as a model for studies on dopamine receptor mechanisms.

Authors:  O S Steinsland; J P Hieble
Journal:  Science       Date:  1978-01-27       Impact factor: 47.728

2.  Circadian variations of plasma catecholamine, cortisol and immunoreactive insulin concentrations in supine subjects.

Authors:  M B Turton; T Deegan
Journal:  Clin Chim Acta       Date:  1974-09-30       Impact factor: 3.786

3.  Diurnal variation of plasma catecholamines and systolic time intervals.

Authors:  W S Aronow; P R Harding; V DeQuattro; M Isbell
Journal:  Chest       Date:  1973-05       Impact factor: 9.410

4.  Metoclopramide increases plasma aldosterone concentration in man.

Authors:  G Norbiato; M Bevilacqua; U Raggi; P Micossi; C Moroni
Journal:  J Clin Endocrinol Metab       Date:  1977-12       Impact factor: 5.958

5.  Plasma and urinary dopamine: studies during fasting and exercise and in tetraplegic man.

Authors:  N J Christensen; C J Mathias; H L Frankel
Journal:  Eur J Clin Invest       Date:  1976-09-10       Impact factor: 4.686

6.  Cycle detection: a technique for estimating the frequency and amplitude of episodic fluctuations in blood hormone and substrate concentrations.

Authors:  D K Clifton; R A Steiner
Journal:  Endocrinology       Date:  1983-03       Impact factor: 4.736

Review 7.  Dopamine (3-hydroxytyramine) and brain function.

Authors:  O Hornykiewicz
Journal:  Pharmacol Rev       Date:  1966-06       Impact factor: 25.468

8.  Dopaminergic control of circadian norepinephrine levels in patients with essential hypertension.

Authors:  J R Sowers
Journal:  J Clin Endocrinol Metab       Date:  1981-12       Impact factor: 5.958

9.  Catecholamine responses to central volume expansion produced by head-out water immersion and saline infusion.

Authors:  G G Krishna; G M Danovitch; J R Sowers
Journal:  J Clin Endocrinol Metab       Date:  1983-05       Impact factor: 5.958

10.  Effects of dietary sodium and of acute saline infusion on the interrelationship between dopamine excretion and adrenergic activity in man.

Authors:  R W Alexander; J R Gill; H Yamabe; W Lovenberg; H R Keiser
Journal:  J Clin Invest       Date:  1974-07       Impact factor: 14.808

View more
  14 in total

Review 1.  Chronotherapy improves blood pressure control and reduces vascular risk in CKD.

Authors:  Ramón C Hermida; Diana E Ayala; Michael H Smolensky; Artemio Mojón; José R Fernández; Juan J Crespo; Ana Moyá; María T Ríos; Francesco Portaluppi
Journal:  Nat Rev Nephrol       Date:  2013-04-23       Impact factor: 28.314

2.  Circadian melatonin rhythm and excessive daytime sleepiness in Parkinson disease.

Authors:  Aleksandar Videnovic; Charleston Noble; Kathryn J Reid; Jie Peng; Fred W Turek; Angelica Marconi; Alfred W Rademaker; Tanya Simuni; Cindy Zadikoff; Phyllis C Zee
Journal:  JAMA Neurol       Date:  2014-04       Impact factor: 18.302

3.  Secretory pattern and blood pressure in pheochromocytoma.

Authors:  S Gröndal; B Hamberger; M Telenius-Berg
Journal:  World J Surg       Date:  1986-08       Impact factor: 3.352

4.  Dopamine Manipulation Affects Response Vigor Independently of Opportunity Cost.

Authors:  Alexandre Zénon; Sophie Devesse; Etienne Olivier
Journal:  J Neurosci       Date:  2016-09-14       Impact factor: 6.167

5.  High concentrations of catecholamines in human hypothalamic-hypophysial blood.

Authors:  R Paradisi; G Frank; G Grossi; S Venturoli; E Porcu; M Capelli; E Galassi; C Flamigni
Journal:  J Clin Invest       Date:  1989-06       Impact factor: 14.808

6.  Platelet activation in nocturnal asthma.

Authors:  J F Morrison; S B Pearson; H G Dean; I R Craig; P N Bramley
Journal:  Thorax       Date:  1991-03       Impact factor: 9.139

7.  Pramipexole in restless legs syndrome: an evidence-based review of its effectiveness on clinical outcomes.

Authors:  William Winlow
Journal:  Core Evid       Date:  2005-03-31

Review 8.  Sleep for cognitive enhancement.

Authors:  Susanne Diekelmann
Journal:  Front Syst Neurosci       Date:  2014-04-02

Review 9.  A Review of Sleep and Its Disorders in Patients with Parkinson's Disease in Relation to Various Brain Structures.

Authors:  Isobel T French; Kalai A Muthusamy
Journal:  Front Aging Neurosci       Date:  2016-05-23       Impact factor: 5.750

10.  Dopamine in plasma - a biomarker for myofascial TMD pain?

Authors:  Andreas Dawson; Niclas Stensson; Bijar Ghafouri; Björn Gerdle; Thomas List; Peter Svensson; Malin Ernberg
Journal:  J Headache Pain       Date:  2016-07-07       Impact factor: 7.277

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.